基因编辑权威指南。
菜单
首页 学习 新闻 向 Atlas 提问
探索 技术 疾病 治疗方法 临床试验 企业 科学家 基因 研究 机构
医学之外 农业 伦理 投资 世界地图
学习与工具 从这里开始 术语表 A–Z 对比技术 时间线 列表与排名 AI 智能体 ★ 已保存 API
关于 关于我们 方法论 数据来源 编辑方针 联系我们 免责声明

🧭 引导视图
遗传学新手?浏览时我们会用简单易懂的语言为您解释每个术语,就在同一页面内,帮助随时可用。

⚡ 专家观点
你已经了解生物学基础,只需内容本身——简洁明了,无额外解释。这是默认视图。

界面语言
浅色模式

伦理 · Human editing

Human embryo research

Editing embryos in the laboratory, without transfer to a uterus, is permitted in some countries and prohibited in others — and it is how the risks of germline editing are actually studied.

How this page is written The Atlas does not take a position on contested ethical questions. Each page sets out the strongest version of the arguments on each side, states what is scientifically settled and what is not, and summarises the law where it exists. Where we think a claim is factually wrong — as opposed to ethically contested — we say so and cite the evidence.

直白的问题

There is a difference between editing an embryo to learn something and editing one to make a baby. The first happens in laboratories under licence in several countries, with embryos destroyed after a limited period and never transferred to a uterus. It is also how researchers discovered that embryo editing is far messier than expected — knowledge that is a central argument against ever doing it reproductively.

Research editing of human embryos without transfer is regulated distinctly from reproductive use. The UK permits it under HFEA licence within the 14-day limit; several countries permit it under national frameworks; others prohibit it entirely. Research has revealed high rates of mosaicism, large on-target deletions and loss of heterozygosity following editing in embryos — findings that materially strengthen the safety case against reproductive use, and that could not have been obtained any other way.

The arguments

支持者的观点
  • It is the only way to understand early human development and why so many pregnancies fail.
  • It generates precisely the safety data needed to evaluate germline claims, rather than speculating.
  • Strict licensing with a firm limit and no transfer is a workable and long-established framework.
  • Model organisms diverge from humans at exactly the developmental stages that matter most.
批评者的观点
  • Some hold that an embryo has moral status making research use impermissible regardless of benefit.
  • Permitting research use may make reproductive use more likely over time.
  • The 14-day limit was a pragmatic convention rather than a principled boundary, and pressure to extend it is now real.

Where the science actually stands

Research editing without transfer is legal under licence in several countries and prohibited in others; positions follow national law and values rather than scientific disagreement. The research itself has produced findings — mosaicism, large deletions, loss of heterozygosity — that are central to why reproductive germline editing is not considered safe.

Law and regulation

司法管辖区职位工具
United Kingdom Permitted under HFEA licence up to 14 days; transfer to a uterus prohibited Human Fertilisation and Embryology Act
United States No federal funding for research destroying embryos; privately funded research permitted in some states Dickey-Wicker Amendment; state law
Germany Highly restricted Embryonenschutzgesetz
Japan Permitted for research under guidelines; reproductive use prohibited National guidelines

本内容仅作概览参考,不构成法律建议;法律会发生变化,各国的具体实施方式也有所不同。请核实相关司法管辖区的现行法律。

Unresolved questions

  • Whether the 14-day limit should be revised now that culture beyond it is technically possible.
  • How to fund and oversee research that many citizens object to on principle.

Sources